메뉴 건너뛰기




Volumn 61, Issue 7, 2014, Pages 1190-1194

Duration of the pre-diagnostic interval in medulloblastoma is subgroup dependent

Author keywords

Genomics; Medulloblastoma; Pediatric brain tumor; Pre diagnostic interval; Subgroups

Indexed keywords

SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

EID: 84899668093     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25002     Document Type: Article
Times cited : (37)

References (33)
  • 2
    • 84857091284 scopus 로고    scopus 로고
    • FISH and chips: The recipe for improved prognostication and outcomes for children with medulloblastoma
    • Ramaswamy V, Northcott PA, Taylor MD. FISH and chips: The recipe for improved prognostication and outcomes for children with medulloblastoma. Cancer Genet 2011; 204:577-588.
    • (2011) Cancer Genet , vol.204 , pp. 577-588
    • Ramaswamy, V.1    Northcott, P.A.2    Taylor, M.D.3
  • 3
    • 0035799137 scopus 로고    scopus 로고
    • Parents' accounts of obtaining a diagnosis of childhood cancer
    • Dixon-Woods M, Findlay M, Young B, et al. Parents' accounts of obtaining a diagnosis of childhood cancer. Lancet 2001; 357:670-674.
    • (2001) Lancet , vol.357 , pp. 670-674
    • Dixon-Woods, M.1    Findlay, M.2    Young, B.3
  • 4
    • 84865139892 scopus 로고    scopus 로고
    • A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma
    • Gerber NU, von Hoff K, von Bueren AO, et al. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma. Eur J Cancer 2012; 38:2028-2036.
    • (2012) Eur J Cancer , vol.38 , pp. 2028-2036
    • Gerber, N.U.1    von Hoff, K.2    von Bueren, A.O.3
  • 5
    • 84859242333 scopus 로고    scopus 로고
    • Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome
    • Brasme J-F, Grill J, Doz F, et al. Long time to diagnosis of medulloblastoma in children is not associated with decreased survival or with worse neurological outcome. PLoS ONE 2012; 7:e33415.
    • (2012) PLoS ONE , vol.7
    • Brasme, J.-F.1    Grill, J.2    Doz, F.3
  • 6
    • 84866884531 scopus 로고    scopus 로고
    • Delays in diagnosis of paediatric cancers: A systematic review and comparison with expert testimony in lawsuits
    • Brasme J-F, Morfouace M, Grill J, et al. Delays in diagnosis of paediatric cancers: A systematic review and comparison with expert testimony in lawsuits. Lancet Oncol 2012; 13:e445-e459.
    • (2012) Lancet Oncol , vol.13
    • Brasme, J.-F.1    Morfouace, M.2    Grill, J.3
  • 7
    • 0036705663 scopus 로고    scopus 로고
    • Latency between symptom onset and diagnosis of pediatric brain tumors: An Eastern Canadian geographic study
    • discussion 372-373.
    • Mehta V, Chapman A, McNeely PD, et al. Latency between symptom onset and diagnosis of pediatric brain tumors: An Eastern Canadian geographic study. Neurosurgery 2002; 51:365-372, discussion 372-373.
    • (2002) Neurosurgery , vol.51 , pp. 365-372
    • Mehta, V.1    Chapman, A.2    McNeely, P.D.3
  • 8
    • 59449108413 scopus 로고    scopus 로고
    • Does diagnostic delay result in decreased survival in paediatric brain tumours
    • Kukal K, Dobrovoljac M, Boltshauser E, et al. Does diagnostic delay result in decreased survival in paediatric brain tumours? Eur J Pediatr 2008; 168:303-310.
    • (2008) Eur J Pediatr , vol.168 , pp. 303-310
    • Kukal, K.1    Dobrovoljac, M.2    Boltshauser, E.3
  • 9
    • 84857051497 scopus 로고    scopus 로고
    • Interval between onset of symptoms and diagnosis of medulloblastoma in children: Distribution and determinants in a population-based study
    • Brasme J-F, Chalumeau M, Doz F, et al. Interval between onset of symptoms and diagnosis of medulloblastoma in children: Distribution and determinants in a population-based study. Eur J Pediatr 2011; 171:25-32.
    • (2011) Eur J Pediatr , vol.171 , pp. 25-32
    • Brasme, J.-F.1    Chalumeau, M.2    Doz, F.3
  • 10
    • 79960152262 scopus 로고    scopus 로고
    • The time to diagnosis in childhood lymphomas and other solid tumors
    • Cecen E, Gunes D, Mutafoglu K, et al. The time to diagnosis in childhood lymphomas and other solid tumors. Pediatr Blood Cancer 2011; 57:392-397.
    • (2011) Pediatr Blood Cancer , vol.57 , pp. 392-397
    • Cecen, E.1    Gunes, D.2    Mutafoglu, K.3
  • 11
    • 84870215426 scopus 로고    scopus 로고
    • Medulloblastomics: The end of the beginning
    • Northcott PA, Jones DT, Kool M, et al. Medulloblastomics: The end of the beginning. Nat Rev Cancer 2012; 12:818-834.
    • (2012) Nat Rev Cancer , vol.12 , pp. 818-834
    • Northcott, P.A.1    Jones, D.T.2    Kool, M.3
  • 12
    • 79955034739 scopus 로고    scopus 로고
    • Medulloblastoma comprises four distinct molecular variants
    • Northcott PA, Korshunov A, Witt H, et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011; 29:1408-1414.
    • (2011) J Clin Oncol , vol.29 , pp. 1408-1414
    • Northcott, P.A.1    Korshunov, A.2    Witt, H.3
  • 13
    • 84860821444 scopus 로고    scopus 로고
    • Molecular subgroups of medulloblastoma: The current consensus
    • Taylor MD, Northcott PA, Korshunov A, et al. Molecular subgroups of medulloblastoma: The current consensus. Acta Neuropathol 2011; 123:465-472.
    • (2011) Acta Neuropathol , vol.123 , pp. 465-472
    • Taylor, M.D.1    Northcott, P.A.2    Korshunov, A.3
  • 14
    • 80053980912 scopus 로고    scopus 로고
    • FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma
    • Remke M, Hielscher T, Korshunov A, et al. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. J Clin Oncol 2011; 29:3852-3861.
    • (2011) J Clin Oncol , vol.29 , pp. 3852-3861
    • Remke, M.1    Hielscher, T.2    Korshunov, A.3
  • 15
    • 84862688169 scopus 로고    scopus 로고
    • Subgroup-specific alternative splicing in medulloblastoma
    • Dubuc AM, Morrissy AS, Kloosterhof NK, et al. Subgroup-specific alternative splicing in medulloblastoma. Acta Neuropathol 2012; 123:485-499.
    • (2012) Acta Neuropathol , vol.123 , pp. 485-499
    • Dubuc, A.M.1    Morrissy, A.S.2    Kloosterhof, N.K.3
  • 16
    • 63449115501 scopus 로고    scopus 로고
    • Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
    • Northcott PA, Nakahara Y, Wu X, et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 2009; 41:465-472.
    • (2009) Nat Genet , vol.41 , pp. 465-472
    • Northcott, P.A.1    Nakahara, Y.2    Wu, X.3
  • 17
    • 79960842253 scopus 로고    scopus 로고
    • Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct
    • Northcott PA, Hielscher T, Dubuc A, et al. Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathol 2011; 122:231-240.
    • (2011) Acta Neuropathol , vol.122 , pp. 231-240
    • Northcott, P.A.1    Hielscher, T.2    Dubuc, A.3
  • 18
    • 84864425646 scopus 로고    scopus 로고
    • Subgroup-specific structural variation across 1,000 medulloblastoma genomes
    • Northcott PA, Shih DJ, Peacock J, et al. Subgroup-specific structural variation across 1, 000 medulloblastoma genomes. Nature 2012; 488:49-56.
    • (2012) Nature , vol.488 , pp. 49-56
    • Northcott, P.A.1    Shih, D.J.2    Peacock, J.3
  • 19
    • 84878857067 scopus 로고    scopus 로고
    • Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma
    • Dubuc AM, Remke M, Korshunov A, et al. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathol 2012; 125:373-384.
    • (2012) Acta Neuropathol , vol.125 , pp. 373-384
    • Dubuc, A.M.1    Remke, M.2    Korshunov, A.3
  • 20
    • 65249186793 scopus 로고    scopus 로고
    • The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors
    • Northcott PA, Fernandez-L A, Hagan JP, et al. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 2009; 69:3249-3255.
    • (2009) Cancer Res , vol.69 , pp. 3249-3255
    • Northcott, P.A.1    Fernandez-L, A.2    Hagan, J.P.3
  • 21
    • 84862776537 scopus 로고    scopus 로고
    • Clonal selection drives genetic divergence of metastatic medulloblastoma
    • Wu X, Northcott PA, Dubuc A, et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 2012; 482:529-533.
    • (2012) Nature , vol.482 , pp. 529-533
    • Wu, X.1    Northcott, P.A.2    Dubuc, A.3
  • 22
    • 84863393028 scopus 로고    scopus 로고
    • Molecular subgroups of medulloblastoma: An international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
    • Kool M, Korshunov A, Remke M, et al. Molecular subgroups of medulloblastoma: An international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 2012; 123:473-484.
    • (2012) Acta Neuropathol , vol.123 , pp. 473-484
    • Kool, M.1    Korshunov, A.2    Remke, M.3
  • 23
    • 79954991010 scopus 로고    scopus 로고
    • Integrative Genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome
    • Cho Y-J, Tsherniak A, Tamayo P, et al. Integrative Genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol 2011; 29:1424-1430.
    • (2011) J Clin Oncol , vol.29 , pp. 1424-1430
    • Cho, Y.-J.1    Tsherniak, A.2    Tamayo, P.3
  • 24
    • 79960119129 scopus 로고    scopus 로고
    • Adult medulloblastoma comprises three major molecular variants
    • Remke M, Hielscher T, Northcott PA, et al. Adult medulloblastoma comprises three major molecular variants. J Clin Oncol 2011; 29:2717-2723.
    • (2011) J Clin Oncol , vol.29 , pp. 2717-2723
    • Remke, M.1    Hielscher, T.2    Northcott, P.A.3
  • 25
    • 84862270168 scopus 로고    scopus 로고
    • The clinical implications of medulloblastoma subgroups
    • Northcott PA, Korshunov A, Pfister SM, et al. The clinical implications of medulloblastoma subgroups. Nat Rev Neurol 2012; 8:340-351.
    • (2012) Nat Rev Neurol , vol.8 , pp. 340-351
    • Northcott, P.A.1    Korshunov, A.2    Pfister, S.M.3
  • 26
    • 84886725191 scopus 로고    scopus 로고
    • Recurrence patterns across medulloblastoma subgroups: An integrated clinical and molecular analysis
    • Ramaswamy V, Remke M, Bouffet E, et al. Recurrence patterns across medulloblastoma subgroups: An integrated clinical and molecular analysis. Lancet Oncol 2013; 14:1200-1207.
    • (2013) Lancet Oncol , vol.14 , pp. 1200-1207
    • Ramaswamy, V.1    Remke, M.2    Bouffet, E.3
  • 27
    • 84892621211 scopus 로고    scopus 로고
    • TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
    • Remke M, Ramaswamy V, Peacock J, et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol 2013; 126:917-929.
    • (2013) Acta Neuropathol , vol.126 , pp. 917-929
    • Remke, M.1    Ramaswamy, V.2    Peacock, J.3
  • 28
    • 84862680481 scopus 로고    scopus 로고
    • Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
    • Northcott PA, Shih DJ, Remke M, et al. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol 2012; 123:615-626.
    • (2012) Acta Neuropathol , vol.123 , pp. 615-626
    • Northcott, P.A.1    Shih, D.J.2    Remke, M.3
  • 29
    • 77950497158 scopus 로고    scopus 로고
    • Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations
    • Tabori U, Baskin B, Shago M, et al. Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations. J Clin Oncol 2010; 28:1345-1350.
    • (2010) J Clin Oncol , vol.28 , pp. 1345-1350
    • Tabori, U.1    Baskin, B.2    Shago, M.3
  • 30
    • 84885423998 scopus 로고    scopus 로고
    • Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma
    • Zhukova N, Ramaswamy V, Remke M, et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol 2013; 31:2927-2935.
    • (2013) J Clin Oncol , vol.31 , pp. 2927-2935
    • Zhukova, N.1    Ramaswamy, V.2    Remke, M.3
  • 31
    • 0035871372 scopus 로고    scopus 로고
    • Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma
    • Halperin EC, Watson DM, George SL. Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma. Cancer 2001; 91:1444-1450.
    • (2001) Cancer , vol.91 , pp. 1444-1450
    • Halperin, E.C.1    Watson, D.M.2    George, S.L.3
  • 32
    • 79951934386 scopus 로고    scopus 로고
    • TP53 mutation is frequently associated with CTNNB1 Mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma
    • Pfaff E, Remke M, Sturm D, et al. TP53 mutation is frequently associated with CTNNB1 Mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol 2010; 28:5188-5196.
    • (2010) J Clin Oncol , vol.28 , pp. 5188-5196
    • Pfaff, E.1    Remke, M.2    Sturm, D.3
  • 33
    • 38349087850 scopus 로고    scopus 로고
    • Brain tumors in children: Initial symptoms and their influence on the time span between symptom onset and diagnosis
    • Reulecke BC, Erker CG, Fiedler BJ, et al. Brain tumors in children: Initial symptoms and their influence on the time span between symptom onset and diagnosis. J Child Neurol 2007; 23:178-183.
    • (2007) J Child Neurol , vol.23 , pp. 178-183
    • Reulecke, B.C.1    Erker, C.G.2    Fiedler, B.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.